Aim: To date, most cognitive behavioural therapy (CBT) trials for individuals with at-risk metal state (ARMS) have been conducted in few Western countries and its feasibility in other regions, including Japan, has not been established.
with ARMS, such medication brings with it the risk of harming physical health (Foley & Morley, 2011 ) and brain structures (Ho, Andreasen, Ziebell, Pierson, & Magnotta, 2011) . One possible explanation for the over-dependence on pharmacotherapy for individuals with ARMS may be insufficient dissemination of evidence-based psychological treatments, including CBT. To date, all randomized-control trials of CBT for ARMS were conducted in limited regions in Western countries (Stafford et al., 2013) , in which CBT is relatively prevalent in usual clinical settings. Only 1 open-trial of CBT for ARMS has been reported from a non-Western country, namely South Korea (Kim et al., 2011) . However, this study had limitations in that 44% participants were treated with antipsychotics during the CBT treatment and the study period of 10 weeks was relatively short. Therefore, we designed an open-label pilot study to explore the feasibility of CBT for individuals with ARMS in a non-Western country, Japan, where CBT is not still sufficiently prevalent and rarely available in usual clinical settings. Because most individuals with ARMS experience a wide range of symptoms, including attenuated positive symptoms, negative symptoms and general psychopathology, we used the total score of the Positive and Negative Syndrome Scale (PANSS) as the primary outcome.
| METHODS
We recruited participants at outpatient clinics of the 4 university hospitals in Japan (Tohoku, Toho, Toyama and Nara) that have specialized services for ARMS, from April 2013 to October 2014. The study protocol was reviewed and authorized by the ethics committee of each study site, and was registered in the national University Hospital Medical Information Network (UMIN) Clinical Trials Registry (ID: UMIN000010382). All participants provided written informed consent, or if subjects were aged <18 year, their parents provided written informed consent while the participant provided written assent.
Inclusion criteria were (1) aged 14 to 35 years, (2) exhibited ARMS criteria using the Comprehensive Assessment of ARMS (CAARMS; Miyakoshi, Matsumoto, Ito, Ohmuro, & Matsuoka, 2009; Yung et al., 2006) and met the attenuated psychosis group criterion, (3) exhibited an impairment in social functioning (GAF score ≤ 50, and/or a reduction by 30% on the GAF for at least 1 month in the past year), (4) native Japanese speaker, (5) outpatient. Exclusion criteria were (1) present or past diagnosis of psychosis, (2) use of antipsychotic medication within the last month or cumulative dose of antipsychotic medication greater than 30 mg of haloperidol-equivalent within the last 6 months, (3) present alcohol or drug abuse, (4) serious risk of suicide or violence, (5) known intellectual disability (IQ < 70) or severe learning disorder, (6) presence of organic brain disorder.
All participants received CBT based on a protocol following the Manchester EDIE Trial , which was published in Japanese. CBT was limited to a maximum of 25 sessions of 50 min each, provided over 6 months, plus up to 6 booster sessions in the subsequent 6 months, if necessary. CBT was provided by clinical psychologists or psychiatrists who had more than 3 years' experience and had received a 2-day workshop before the trial. Therapists were encouraged to adapt CBT for young Japanese participants, who may be hesitant to assert themselves and compliant with therapists' advice. This enabled the principles of CBT to be maintained, particularly establishment of a collaborative relationship and guided discovery. All participants were clinically followed-up by a psychiatrist in charge and received standard psychiatric treatment including a brief intervention and the prescription of psychotropic drugs if necessary. All CBT sessions were recorded and regularly supervised by the chief investigator (K. M.) and/or therapists at each institution. Regular workshop meetings were conducted to ensure that each therapist followed the protocol. Two samples of audio data from each participant were rated using the Cognitive Therapy Rating Scale (CTRS; Young & Beck, 1980) , which is available in Japanese, by an independent rater (Y.K.). The average CTRS total score of the sessions was 42.9 (SD = 4.6, range 37-51).
The primary outcome was the total score on the Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987) and secondary outcomes included PANSS subscale scores and positive symptoms by the CAARMS (Miyakoshi et al., 2009; Yung et al., 2006) . We also measured clinical variables using the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) , the State-Trait Anx- Friedman 2-way analysis of variance by ranks was conducted to analyse differences between measurements at baseline, postintervention (6 months), and at follow-up (12 months). Single posthoc comparisons were calculated using the Wilcoxon signed-rank test with Bonferroni correction for multiple comparisons. We calculated within-group effect sizes using Cohen's d. Statistically significant differences were determined by 2-tailed test, with a significance of P < .05. All statistical analyses were performed using IBM SPSS Statistics ver. 23.0 for Windows (SPSS Inc., Chicago, Illinois).
| RESULTS
In total, 14 individuals participated in this study. One individual was considered to have exhibited protocol deviation because CBT sessions were provided beyond the 6-month intervention period and most of the post-baseline data were not obtained; therefore, this individual was excluded from further analysis. Table 1 The number of participants who met ARMS criteria reduced from baseline to 6 (n = 7) and 12 months (n = 2). One participant transitioned to psychosis, received antipsychotics, and was admitted to hospital for 3 days after the intervention period, between 6 and 12 months. No other participant received antipsychotics or was admitted to hospital. Table 2 shows the outcome measures. The PANSS total score was significantly different among the 3 time points. Post-hoc tests confirmed the improvement of the scores from baseline to 6 and 12 months, with large effect sizes (Cohen, 1988) . All other clinical measures other than negative symptoms also improved from baseline to 6 and 12 months.
| DISCUSSION
In the present study, we confirmed the feasibility of the provision of CBT for ARMS in a Japanese clinical setting. The primary outcome of the study, namely the total PANSS score, significantly improved from baseline to post-intervention and follow-up assessments, and large effect sizes were observed for the improvements. No participant dropped out from the study and the average number of CBT sessions was 16.5, which is higher than in previous studies (range 9-12; Addington et al., 2011; McGorry et al., 2013; Morrison et al., 2012; Morrison et al., 2004; van der Gaag et al., 2012) . Participants were satisfied with CBT; it was well accepted by these clients.
In the present study, significant clinical improvement was observed without the use of antipsychotics, except for a patient who transitioned to psychosis. Minimizing the use of antipsychotics for individuals with ARMS is preferable because the use of antipsychotics may induce health problems and brain volume reduction (Ho et al., 2011) . Further, the risk-benefit ratio of antipsychotics for the young population may be relatively low compared to the adult population (Stafford et al., 2015) . Excessive use of antipsychotics for ARMS and overdiagnosis of schizophrenia is matter of great concern in Japan, and probably also in many other areas, with the exception of a limited number of Western regions (Katsura et al., 2014; Mizuno, Nemoto, Tsujino, Funatogawa, & Takeshi, 2012) . Promoting evidence-based psychological therapy including CBT appears a promising approach to increase treatment efficacy and minimize the use of antipsychotics.
The present study has limitations, including small sample size, lack of matched control group and open-label design. In addition, the present study was conducted in university hospitals that have clinical service for ARMS, clinicians were trained and familiar with interventions for individuals with ARMS, and therapists were trained in CBT and supervised regularly. Since such clinical and educational conditions are not common in Japan, improving education for psychiatrists and implementing an appropriate clinical service system including training for CBT is necessary to increase generalizability of the present study to usual clinical settings.
